Study: GPs inflate valuations during fundraising(2)

A University of Oxford analysis of CalPERS’ private equity portfolio has found that GPs inflate valuations of existing portfolio companies while marketing follow-on funds.

23 January 2014•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail